Nifty Pharma Today: Index Down 0.51% in Early Trade

Quick sector takeaways

• Nifty Pharma traded at 26,656.45, down 136.20 points or 0.51% from its previous close of 26,792.65 in the early session on 2 September 2026.
• The index moved between 26,642.95 and 26,788.60, placing the latest level close to the session low at the 10:00 AM IST update.
• Breadth was weak: 2 of 20 tracked pharma stocks advanced, while 18 declined. Mankind Pharma and Sun Pharmaceutical Industries were the two gainers.
• Watch whether the index can move away from its intraday low and whether broader participation improves beyond the two advancing stocks.

Nifty pharma today reflects a softer early-session tone, even as the index ranked as the top gaining sector index within the configured sector set on a relative basis. The designation refers to relative performance against the other tracked sector indices, not to a positive absolute move.

Nifty Pharma today: early-session update

Nifty Pharma opened at 26,668.50 and was at 26,656.45 at 10:00 AM IST, compared with the previous close of 26,792.65. That translates into a decline of 136.20 points, or 0.51%. The index was therefore below both its previous close and opening level during the opening-bell session.

The early price action showed a contained but negative range. After reaching 26,788.60 during the session, Nifty Pharma slipped to a low of 26,642.95. The latest reading stood just 13.50 points above that low and 132.15 points below the day high. This is a price-position observation from the morning range rather than an indication of what the index may do next.

For readers following the sector screen, the immediate picture is one of modest index-level pressure accompanied by a much weaker distribution of stock moves. The gap between the index’s 0.51% decline and the 18-to-2 decline-to-advance split makes breadth a central part of the opening update.

Price snapshot

The session range so far is 145.65 points, measured from the day low to the day high. Since the latest value is near the lower end of that range, investors tracking nifty pharma today can focus on whether the sector sees a wider recovery in its stock-level participation as trade develops.

Sector ranking

Nifty Pharma was selected as the top gaining sector index among the configured sector indices because it was the best relative performer in that group at the available update. Its 0.51% decline was smaller than the moves recorded by Nifty Bank (-0.60%), Nifty Metal (-0.87%), Nifty FMCG (-0.91%), Nifty Financial Services (-0.93%), Nifty Mid Select (-1.19%), Nifty IT (-1.29%) and Nifty Auto (-2.20%).

That relative ranking matters because sector leadership can be comparative. In this instance, Nifty Pharma was comparatively resilient within the configured set while still trading below its own previous close. The ranking should therefore be read alongside the actual point and percentage movement, rather than as a description of an advancing index.

Constituent breadth

The sector’s breadth was distinctly negative in the early session. Of 20 display-safe stocks, 2 advanced and 18 declined, with no unchanged stocks. The advance-decline ratio was 0.11, meaning the number of decliners was substantially higher than the number of advancers.

This breadth profile aligns with the index’s negative move and shows that the softness was spread across most of the tracked pharma names. Mankind Pharma and Sun Pharmaceutical Industries held in positive territory, but their gains did not translate into broad-based participation across the sector at this stage of trade.

Heavyweights versus broader participation

Among the named heavyweight stocks, Sun Pharmaceutical Industries was up 0.36% at Rs 1,935.90. Divi’s Laboratories was down 0.50% at Rs 9,119, Torrent Pharmaceuticals declined 0.22% to Rs 4,954.50, Cipla fell 1.27% to Rs 1,404.90, and Dr. Reddy’s Laboratories was lower by 0.51% at Rs 1,165.

The listed active names echoed this mixed heavyweight picture: Sun Pharmaceutical Industries was positive, while Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories were in the red. This combination underlines that the sector’s relative resilience versus other configured indices coexisted with negative participation among several large, closely followed pharma stocks.

Key Nifty Pharma stocks

Biggest positive movers

Mankind Pharma led the gainers, rising 0.55% to Rs 2,369.40 after trading between Rs 2,341.20 and Rs 2,378.50. Sun Pharmaceutical Industries gained 0.36% to Rs 1,935.90, with an intraday range of Rs 1,910 to Rs 1,948.50. These were the only two positive stock moves in the sector at the update.

The gains in these names provide the constructive evidence within an otherwise negative breadth reading. Sun Pharmaceutical Industries was also trading above its opening level of Rs 1,910, while Mankind Pharma was above its opening price of Rs 2,351.

Biggest negative movers

JB Chemicals & Pharmaceuticals was the largest decliner, down 3.87% to Rs 2,408.90. Laurus Labs fell 1.94% to Rs 1,825.50, Ajanta Pharma declined 1.81% to Rs 3,441.30, Granules India was lower by 1.74% at Rs 822.60, and Gland Pharma dropped 1.53% to Rs 2,831.10.

Ajanta Pharma’s latest price matched its day low of Rs 3,441.30. Laurus Labs, at Rs 1,825.50, was close to its day low of Rs 1,822.60. These are intraday observations that help describe where the stocks stood in their morning ranges.

Stocks to watch next session

• Sun Pharmaceutical Industries, for whether its positive move continues to stand apart within the sector.
• Mankind Pharma, after leading the gainers with a 0.55% advance.
• JB Chemicals & Pharmaceuticals, following the steepest percentage decline.
• Laurus Labs, which traded near its intraday low in the early session.
• Cipla, given its 1.27% fall among the named heavyweight stocks.
• Divi’s Laboratories, which was down 0.50% while remaining a key heavyweight name.

The constructive case

The constructive evidence is primarily relative and selective. Nifty Pharma was the best-performing index among the configured sector set despite its 0.51% decline. Within the sector, Mankind Pharma and Sun Pharmaceutical Industries advanced, and Sun Pharmaceutical Industries provided a positive move among the named heavyweights. The index also remained above its day low at the time of the update.

These points do not offset the negative opening move, but they show where early-session resilience was visible: relative sector ranking, two advancing stocks, and a positive move in a prominent heavyweight.

The cautious case

The cautious case is clearer in the breadth data. Eighteen of 20 tracked stocks were lower, with no unchanged names. Several heavyweight and actively tracked stocks, including Cipla, Divi’s Laboratories, Torrent Pharmaceuticals and Dr. Reddy’s Laboratories, were in negative territory. The index also traded below its previous close and opening level, with the latest value close to the day low.

The largest individual declines were concentrated in JB Chemicals & Pharmaceuticals, Laurus Labs, Ajanta Pharma, Granules India and Gland Pharma. For the early session, these price moves indicate a broad negative skew across the sector.

Univest Insights

Nifty pharma today presents a useful distinction between relative leadership and absolute direction. The sector ranked first among the configured indices because it fell less than peers, but its own price change remained negative. Reading both measures together gives a more complete view of the opening session.

The morning range of 26,642.95 to 26,788.60 provides the immediate context for the index. At 26,656.45, the sector was closer to the lower boundary of that range. That makes the evolving price position within the day’s range a simple factual marker for subsequent updates.

Stock-level breadth is the other major signal. Gains in Mankind Pharma and Sun Pharmaceutical Industries stood against declines across the rest of the tracked list. A broader improvement in participation would look different from a session driven by only a limited number of advancing names.

For a wider market context, visit Univest Market View. For traders and investors, the key signal to watch is…

Published on 2 September 2026 at 10:00 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,656.45 at 10:00 AM IST on 2 September 2026, down 136.20 points or 0.51% from its previous close of 26,792.65.

Why was Nifty Pharma called the top gaining sector index despite falling?

It was the best relative performer among the configured sector indices. Its 0.51% decline was smaller than the declines recorded by the other indices in that group.

What were Nifty Pharma’s day high and day low?

The day high was 26,788.60 and the day low was 26,642.95 at the available early-session update.

How was the Nifty Pharma breadth?

Of 20 tracked stocks, 2 advanced and 18 declined, while none were unchanged.

Which stocks gained in Nifty Pharma?

Mankind Pharma rose 0.55% and Sun Pharmaceutical Industries gained 0.36% in the early session.

Which stocks were the biggest losers in Nifty Pharma?

JB Chemicals & Pharmaceuticals fell 3.87%, followed by Laurus Labs at 1.94%, Ajanta Pharma at 1.81%, Granules India at 1.74% and Gland Pharma at 1.53%.